All News
Filter News
Found 809,010 articles
-
908 Devices to Report Third Quarter Financial Results on November 4, 2021
10/21/2021
908 Devices Inc. today announced it will report financial results for the third quarter 2021 before market open on Thursday, November 4, 2021.
-
Apria to Announce Third Quarter 2021 Financial Results
10/21/2021
Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes.
-
Taysha Gene Therapies to Participate in Upcoming Gene Therapy Summit
10/21/2021
Taysha Gene Therapies, Inc. today announced its participation in a fireside chat at the Jefferies Gene Therapy & Editing Summit.
-
Blueprint Medicines to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021
10/21/2021
Blueprint Medicines Corporation today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, October 28, 2021 to report its third quarter 2021 financial results and provide a corporate update.
-
Tabula Rasa HealthCare Schedules Third Quarter 2021 Earnings Conference Call
10/21/2021
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) , will hold a conference call and webcast to discuss its third quarter 2021 operating results Friday, November 5, 2021 at 8:30 a.m. EDT
-
Precision BioSciences to Present at the Jefferies Virtual Gene Therapy/Editing Summit on Thursday, October 27, 2021
10/21/2021
Precision BioSciences, Inc. today announced that Derek Jantz, Ph.D., Chief Scientific Officer and Co-Founder, will present at the Jefferies Virtual Gene Therapy/Gene Editing Summit, being held October 27-28, 2021.
-
Dynavax to Report Third Quarter 2021 Financial Results and Host Conference Call on November 4, 2021
10/21/2021
Dynavax Technologies Corporation will report third quarter 2021 financial results on Thursday, November 4, 2021, after the U.S. financial markets close.
-
iSpecimen® to Report Third Quarter 2021 Results on November 4, 2021
10/21/2021
iSpecimen Inc. today announced that it will report its financial results for the third quarter ended September 30, 2021 , before the market open on Thursday, November 4, 2021 .
-
LogicBio Therapeutics Announces Successful Repopulation of Diseased Livers in Mice with Healthy Corrected Hepatocytes in Two New Indications Using GeneRide™ Genome Editing Technology
10/21/2021
LogicBio Therapeutics, Inc. today is slated to present new preclinical data on its GeneRide™ platform at the European Society of Gene and Cell Therapy (ESGCT) Virtual Congress 2021, taking place October 19-22, 2021.
-
PharmaEssentia Announces Pipeline Presentation During Upcoming American Society of Hematology Annual Meeting
10/21/2021
PharmaEssentia Corporation today announced plans to present new updates on its pipeline during the 63rd American Society of Hematology Annual Meeting, December 11-14, 2021.
-
Indivior to Present New Data on Opioid Use Disorder at CSAM-SMCA 2021 Scientific Conference
10/21/2021
Indivior PLC (LON: INDV) today announced the presentation of new data from multiple posters and presentations at the Canadian Society of Addiction Medicine – La Société Médicale Canadienne sur L'addiction (CSAM-SMCA) 2021 Scientific Conference, taking place virtually October 21-23, 2021 .
-
Vericel to Report Third-Quarter 2021 Financial Results on November 9, 2021
10/21/2021
Vericel Corporation today announced the following webcast and conference call to discuss its third-quarter 2021 financial results and business highlights.
-
Antares Pharma to Report Third Quarter 2021 Financial and Operating Results
10/21/2021
Antares Pharma, Inc. today announced it will release its third quarter 2021 financial and operating results on Thursday, November 4, 2021, before the market opens.
-
Silence Therapeutics Provides mRNAi GOLD™ Platform and Pipeline Updates at 2021 R&D Day
10/21/2021
Silence Therapeutics plc announces it is hosting its R&D Day in New York City today.
-
Phathom Pharmaceuticals to Present New Data at ACG 2021 Annual Scientific Meeting
10/21/2021
Phathom Pharmaceuticals, Inc. will be presented at the ACG 2021 Annual Scientific Meeting in Las Vegas, Nevada, organized by the American College of Gastroenterology, October 22-27.
-
Zogenix to Release Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4
10/21/2021
Zogenix today announced data that it will report its financial results for the third quarter ended September 30, 2021 and host a corporate update conference call and webcast after the market close on Thursday, November 4, 2021, at 4:30 PM Eastern Time.
-
Adagene to Participate in the Jefferies Virtual China Biotech Summit
10/21/2021
Adagene Inc. today announced that Adagene’s Co-founder, Chief Executive Officer and Chairman, Peter Luo, Ph.D., will provide a corporate update and participate in one-on-one investor meetings at the Jefferies Virtual China Biotech Summit to be held October 26, 2021.
-
Calithera Biosciences to Present First Clinical Data from Development Program for Arginase Inhibitor CB-280 at NACFC 2021
10/21/2021
Calithera Biosciences, Inc. today announced that data from its Phase 1b trial of CB-280, the company’s investigational arginase inhibitor for the treatment of cystic fibrosis (CF), will be shared in a poster presentation at the North American Cystic Fibrosis Conference (NACFC), taking place virtually November 2-5, 2021.
-
Alimera Sciences to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021, and Provide Corporate UpdateConference Call to be held Thursday, October 28, 2021, at 9:00am Eastern Time
10/21/2021
Alimera Sciences, Inc. announces today that it will report third quarter 2021 financial results on Thursday, October 28, 2021, prior to the market open.
-
Cocrystal Pharma to Present Data from its Oral and Intranasal COVID-19 Therapeutics Programs at the World Antiviral Congress 2021
10/21/2021
Cocrystal Pharma, Inc. announces that President and co-interim CEO Dr. Sam Lee will present new data from its COVID-19 programs at the World Antiviral Congress 2021 being held in San Diego.